Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) saw a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 96,000 shares, an increase of 115.7% from the October 15th total of 44,500 shares. Based on an average daily trading volume, of 35,155 shares, the short-interest ratio is currently 2.7 days.
Voyageur Pharmaceuticals Stock Up 0.5%
OTCMKTS VYYRF traded up $0.00 during midday trading on Friday, hitting $0.09. 40,000 shares of the company traded hands, compared to its average volume of 31,186. The company’s 50-day simple moving average is $0.10 and its 200-day simple moving average is $0.10. Voyageur Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.03.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd. is a Canadian specialty pharmaceutical company focused on the development and manufacture of barium sulfate products used as contrast agents in diagnostic medical imaging. Barium sulfate is administered orally or rectally to help improve the visibility of the gastrointestinal tract during X-ray and computed tomography examinations. The company’s activities include the production of pharmaceutical-grade barium sulfate and the development of finished contrast-media formulations for healthcare and diagnostic-imaging markets.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
